A Case Report of Latent Peri-Partum Cardiomyopathy, Obscured by Hypertension
A B S T R A C T
Peripartum Cardiomyopathy (PPCM) is a pregnancy-associated cardiac disorder, which is potentially life-threatening and manifests as left ventricular dysfunction and heart failure. The disease is rather rare and in most patients cardiac function recovers well, but long-term morbidity and mortality are not uncommon. Research studies suggest pregnancy-induced hormones and mediators, which cause vascular dysfunction, trigger that peri-partum cardiomyopathy. Genetic factors are also thought to play a role in pathophysiology. Management of peri-partum cardiomyopathy is same as cardiac failure and drugs against mediators like prolactin are under investigations, but no proven disease-specific therapies had been reported. We report a case of 35-year-old female who, instead of heart failure, had hypertension as sole presenting complaint of PPCM. Complications associated with PPCM are severe progressive heart failure, arrhythmias, heart block, cardiopulmonary block and thromboembolism. Death could be caused by worsening heart failure, arrhythmias and cardiopulmonary block.
Keywords
Peri-partum cardiomyopathy, hypertension, pregnancy, heart failure
Introduction
Peri-partum Cardiomyopathy (PPCM) is an uncommon but serious cardiac disorder of unknown etiology that typically occurs in the peri-partum period, characterized by left ventricular systolic impairment and presenting with symptoms of heart failure [1]. Diagnosis is based on the following criteria, 1) heart failure towards the end of pregnancy or early postpartum period, 2) left ventricular systolic dysfunction based on echocardiography showing left ventricular ejection fraction (LVEF) <50%, fractional shortening <30% or both, 3) no previous history of heart disease prior to pregnancy, 4) no known etiology [2, 3]. Prevalence is reported to be 1 in 400 live births in Haiti, 1 in 1000 live births in South Africa, 1 in 3000-4000 live births in United States and 1 in 20000 live births in Japan [4, 5]. Risk factors associated with PPCM are hypertensive disorders of pregnancy (HDP), African American race, advanced maternal age, multiple pregnancy, obesity, smoking and genetics [2, 6, 7]. Exact pathophysiology of PPCM is not fully understood but many theories have described association of PPCM with viral myocarditis, autoimmune origin, endothelial and cardio toxic factors like soluble FLT1 (sFLT1), and cleaved prolactin [8].
Case Presentation
A 35-year-old female with history of Cesarean section 5 days back presented to the ER with signs and symptoms of intestinal perforation. Vitals were, BP= 159/98, Pulse=93/min, Temp= 98.9F, RR=20/min. She was investigated accordingly and emergency exploratory laparotomy was planned. IV lines secured and she was resuscitated with fluids and antibiotics. Patient was also catheterized and NG tube was passed for gastric decompression. Physical examination showed absent bowel sounds and did not reveal any abnormal breathing or heart sounds in chest. Patient's history revealed that pregnancy was uncomplicated during the preterm, labor/cesarean section and post-surgery period. There was no history of primary hypertension, pregnancy induced hypertension, pre-eclampsia, eclampsia, diabetes mellitus or any cardiac issues. She had no proteinuria or edema during antenatal visits.
Patient was shifted to operation theatre and given general anaesthesia as planned, cardiac monitor with EKG leads attached for continuous vital monitoring. Surgery was started and abdomen was opened when suddenly the blood pressure of patient started to fall rapidly. So much so that patient became blood pressure-less/pulseless and oxygen saturation fell below 20%. Urgent resuscitation efforts started with chest compressions and IV Adrenaline. Patient responded to resuscitation efforts and was put on cardiac support with continuous slow IV adrenaline infusion. Meanwhile the patient's chest revealed generalized crackles. Fluid was restricted, Furosemide given for diuresis and patient responded well. Surgery was continued as blood pressure stabilized and at the end of surgery patient was off cardiac support. After surgery the patient was in a very stable condition with blood pressure returning close to baseline readings of 153/96. Patient was shifted to ICU for nursing care with clear instructions of fluid restriction.
Figure 1: Figure shows the findings of Cardiac Echocardiogram, showing reduced ejection fraction of 40%, fractional shortening 22%, mitral regurgitation, left ventricular dilation, hypokinesia of interventricular septum, apex and apical segments of A/W.
Next morning one of the nurses by mistake started fluid infusion and the patient once again went to cardiac depression and shock. But this time patient was managed robustly by stopping the infusion, injecting adrenaline and furosemide. As soon the patient was stable, Cardiac Echocardiogram was performed that revealed reduced ejection fraction of 40%, fractional shortening 22%, mitral regurgitation, left ventricular dilation, hypokinesia of interventricular septum, apex and apical segments of A/W. Figure 1 shows the echocardiographic findings. Other labs for differential diagnosis including cardiac enzymes were normal. EKG showed normal sinus rhythm. A diagnosis of peri-partum cardiomyopathy with a typical presentation of hypertension was made based on the above-mentioned criteria. Cardiology facility was involved and patient was managed conservatively with fluid restriction, diuretics and continuous vital monitoring. On fifth day patient was stable, oral free, ambulatory, and going to toilet without any difficulty. She was shifted back to parent ward and later on discharged home with follow up with cardiology in 1 week. Patient was followed for 6 months on for heart failure medications and her blood pressure normalized in the range of 118-133/75-92. Ejection fraction was 55%-60% on follow up echocardiography. She is in good health without any sequel.
Discussion
Historically risk factors for PPCM occur mostly in old black women but this trend is changing towards young women, favored by this case report, as the patient is young Asian female. Other risk factors are hypertensive disorders of pregnancy like eclampsia; multi-fetal pregnancy, obesity etc. The unique feature in this patient was that she did not have any presenting features like dyspnea or symptoms of heart failure before she was given intravenous fluid. The only notable finding was hypertension at presentation, which was thought to be due to stress of peritonitis. This hypertension also confounded the diagnosis of PPCM during surgery in the first place. But it was later described that hypertension was related to PPCM and it was the only presenting feature. This is a unique finding never described before for PPCM. Although hypertensive disorders of pregnancy are strongly associated with PPCM, this patient did not have any history of hypertension before the presentation for intestinal obstruction, no history of hypertension in antenatal period as well [9]. Hence a diagnosis of PPCM with atypical presentation of hypertension was made after further findings of echocardiography and diagnostic criteria described above.
Many theories have been proposed to describe the pathophysiology of PPCM postulating that it might be caused cardiovascular stress of pregnancy due to fluid retention, others suggest inflammatory response to pregnancy, yet others say autoimmune response to fetal cells and other mediators that lodge in the myocardium. Histologic findings of cardiac biopsy also show inflammatory process in many patients with PPCM. Diagnosis is made on the criteria mentioned above. Echocardiography shows decrease in ejection fraction, hypokinesia. Chest X-ray shows pulmonary congestion, increased cardiac size and sometimes pulmonary effusions. ECG is typically non-revealing. Other investigations including BNP are neither helpful nor necessary. But cardiac enzymes and pre-eclampsia must be ruled out. Treatment is the same as that of heart failure including diuretics, beta-blockers, digoxin and lifestyle modifications of fluid and salt restriction [10, 11]. ACE inhibitors and angiotensin receptors blockers can be used post-partum but contraindicated in pregnancy [12]. Due to the implication of prolactin components in the pathogenesis of the disease, prolactin antagonist Bromocriptine is being investigated as a treatment with favorable results [13, 14]. Medical treatment is continued for at least one year and then can be adjusted based on the symptoms. Failure of medical treatment warrants heart transplant as last option [15].
Conclusion
Majority of PPCM cases present in patients with normal blood pressures but hypertensive disorders of pregnancy are most important independent risk factors that may aggravate the heart failure associated with this disease. PPCM presents with slowly progressive dyspnea, lower extremity edema and features of worsening heart failure. It may present with hypertension only, and heart failure may ensue after external stress, like intravenous fluids, is applied to already compensated cardiac function, triggering sudden collapse of the patient.
Conflicts of Interest
None.
Acknowledgments
We are grateful to Prof. Dr Muhammad Shahid and Dr. Saeeda Bano from DHQ Teaching Hospital Sahiwal, for helpful discussion and advices for the conceptualization and analysis of the manuscript.
Article Info
Article Type
Case ReportPublication history
Received: Sat 27, Jun 2020Accepted: Thu 09, Jul 2020
Published: Fri 31, Jul 2020
Copyright
© 2023 Muhammad Mubin. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Hosting by Science Repository.DOI: 10.31487/j.JICOA.2020.04.05
Author Info
Adeel Riaz Muhammad Mubbashir Sheikh Hafiz Muhammad Umair Muhammad Shah Nawaz ul Rehman Iram Liaqat Muhammad Mubin
Corresponding Author
Muhammad MubinCenter of Agricultural Biochemistry and Biotechnology, University of Agriculture, Faisalabad, Pakistan
Figures & Tables
References
- Karen Sliwa, Denise Hilfiker Kleiner, Mark C Petrie, Alexandre Mebazaa, Burkert Pieske et al. (2010) Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail 12: 767-778. [Crossref]
- R A C Hughes, P Kapur, G C Sutton, M Honey (1970) A case of fatal peri-partum cardiomyopathy. Br Heart J 32: 272-276. [Crossref]
- Ntobeko B A Ntusi, Motasim Badri, Freedom Gumedze, Karen Sliwa, Bongani M Mayos (2015) Pregnancy‐associated heart failure: a comparison of clinical presentation and outcome between hypertensive heart failure of pregnancy and idiopathic peripartum cardiomyopathy. PLoS One 10: e0133466. [Crossref]
- James D Fett, Len G Christie, Robert D Carraway, Joseph G Murphy (2005) Five‐year prospective study of the incidence and prognosis of peripartum cardiomyopathy at a single institution. Mayo Clin Proc 80: 1602-1606. [Crossref]
- Erica P Gunderson, Lisa A Croen, Vicky Chiang, Cathleen K Yoshida, David Walton et al. (2011) Epidemiology of peripartum cardiomyopathy: incidence, predictors and outcomes. Obstet Gynecol 118: 583-591. [Crossref]
- David P Kao, Eileen Hsich, JoAnn Lindenfeld (2013) Characteristics, adverse events, and racial differences among delivering mothers with peripartum cardiomyopathy. JACC Heart Fail 1: 409-416. [Crossref]
- Lori A Blauwet, Leslie T Cooper (2011) Diagnosis and management of peripartum cardiomyopathy. Heart 97: 1970-1981. [Crossref]
- Denise Hilfiker Kleiner, Karol Kaminski, Edith Podewski, Tomasz Bonda, Arnd Schaefer et al. (2007) A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell 128: 589-600. [Crossref]
- Ida Behrens, Saima Basit, Jacob A Lykke, Mattis F Ranthe, Jan Wohlfahrt et al. (2019) Hypertensive disorders of pregnancy and peripartum cardiomyopathy: A nationwide cohort study. PLoS One 14: e0211857. [Crossref]
- Karen Sliwa, James Fett, Uri Elkayam (2006) Peripartum cardiomyopathy. Lancet 368: 687-693. [Crossref]
- Daniel J Egan, Mark C Bisanzo, H Range Hutson (2009) Emergency department evaluation and management of peripartum cardiomyopathy. J Emerg Med 36: 141-147. [Crossref]
- Christof Schaefer (2003) Angiotensin II‐receptor‐antagonists: further evidence of fetotoxicity but not teratogenicity. Birth Defects Res A Clin Mol Teratol 67: 591-594. [Crossref]
- Gerd Peter Meyer, Saida Labidi, Edith Podewski, Karen Sliwa, Helmut Drexler et al. (2010) Bromocriptine treatment associated with recovery from peripartum cardiomyopathy in siblings: two case reports. J Med Case Rep 4: 80. [Crossref]
- Boriana G Jahns, Werner Stein, Denise Hilfiker Kleiner, Burkert Pieske, Günter Emons (2008) Peripartum cardiomyopathy–a new treatment option by inhibition of prolactin secretion. Am J Obstet Gynecol 199: e5-e6. [Crossref]
- Kismet D Rasmusson, Josef Stehlik, Robert N Brown, Dale G Renlund, Lynne E Wagoner et al. (2007) Long‐term outcomes of cardiac transplantation for peri-partum cardiomyopathy: a multi institutional analysis. J Heart Lung Trans 26: 1097-1104. [Crossref]